Cargando…
Primary Neuroendocrine Tumor of the Scrotum: An Uncommon Site for a Rare Tumor
Neuroendocrine tumors (NETs) are a heterogeneous group of tumors developing from neural crest cells, with numerous sites of origin, commonly the gastrointestinal and genitourinary tracts. NETs of the genitourinary tract are more common in women. Small cell carcinoma of the prostate or testicular car...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040611/ https://www.ncbi.nlm.nih.gov/pubmed/33834875 http://dx.doi.org/10.1177/23247096211008717 |
_version_ | 1783677818466467840 |
---|---|
author | Akhtar, Komal Vyas, Vrinda Ashok Kumar, Prashanth Corines, James de la Roza, Gustavo Basnet, Alina |
author_facet | Akhtar, Komal Vyas, Vrinda Ashok Kumar, Prashanth Corines, James de la Roza, Gustavo Basnet, Alina |
author_sort | Akhtar, Komal |
collection | PubMed |
description | Neuroendocrine tumors (NETs) are a heterogeneous group of tumors developing from neural crest cells, with numerous sites of origin, commonly the gastrointestinal and genitourinary tracts. NETs of the genitourinary tract are more common in women. Small cell carcinoma of the prostate or testicular carcinoid are the NETs in male. In this article, we present a rare case of NET of the scrotum. Our patient was a 47-year-old male with a history of complicated pilonidal cysts resulting in chronic scrotal wounds. Biopsy of a large nonhealing scrotal wound revealed a high-grade neuroendocrine carcinoma with features most suggestive of small cell carcinoma. Presenting with advanced disease at diagnosis, he was started on systemic therapy and unfortunately progressed through multiple lines of treatment, including CAPTEM (capecitabine and temozolomide). Unfortunately, due to multiple logistical reasons, the patient was unable to receive the then off-label immunotherapy based on DART (Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors) trial. He, unfortunately, succumbed to his disease within months of diagnosis. |
format | Online Article Text |
id | pubmed-8040611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-80406112021-04-21 Primary Neuroendocrine Tumor of the Scrotum: An Uncommon Site for a Rare Tumor Akhtar, Komal Vyas, Vrinda Ashok Kumar, Prashanth Corines, James de la Roza, Gustavo Basnet, Alina J Investig Med High Impact Case Rep Case Report Neuroendocrine tumors (NETs) are a heterogeneous group of tumors developing from neural crest cells, with numerous sites of origin, commonly the gastrointestinal and genitourinary tracts. NETs of the genitourinary tract are more common in women. Small cell carcinoma of the prostate or testicular carcinoid are the NETs in male. In this article, we present a rare case of NET of the scrotum. Our patient was a 47-year-old male with a history of complicated pilonidal cysts resulting in chronic scrotal wounds. Biopsy of a large nonhealing scrotal wound revealed a high-grade neuroendocrine carcinoma with features most suggestive of small cell carcinoma. Presenting with advanced disease at diagnosis, he was started on systemic therapy and unfortunately progressed through multiple lines of treatment, including CAPTEM (capecitabine and temozolomide). Unfortunately, due to multiple logistical reasons, the patient was unable to receive the then off-label immunotherapy based on DART (Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors) trial. He, unfortunately, succumbed to his disease within months of diagnosis. SAGE Publications 2021-04-09 /pmc/articles/PMC8040611/ /pubmed/33834875 http://dx.doi.org/10.1177/23247096211008717 Text en © 2021 American Federation for Medical Research https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Report Akhtar, Komal Vyas, Vrinda Ashok Kumar, Prashanth Corines, James de la Roza, Gustavo Basnet, Alina Primary Neuroendocrine Tumor of the Scrotum: An Uncommon Site for a Rare Tumor |
title | Primary Neuroendocrine Tumor of the Scrotum: An Uncommon Site for a Rare Tumor |
title_full | Primary Neuroendocrine Tumor of the Scrotum: An Uncommon Site for a Rare Tumor |
title_fullStr | Primary Neuroendocrine Tumor of the Scrotum: An Uncommon Site for a Rare Tumor |
title_full_unstemmed | Primary Neuroendocrine Tumor of the Scrotum: An Uncommon Site for a Rare Tumor |
title_short | Primary Neuroendocrine Tumor of the Scrotum: An Uncommon Site for a Rare Tumor |
title_sort | primary neuroendocrine tumor of the scrotum: an uncommon site for a rare tumor |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040611/ https://www.ncbi.nlm.nih.gov/pubmed/33834875 http://dx.doi.org/10.1177/23247096211008717 |
work_keys_str_mv | AT akhtarkomal primaryneuroendocrinetumorofthescrotumanuncommonsiteforararetumor AT vyasvrinda primaryneuroendocrinetumorofthescrotumanuncommonsiteforararetumor AT ashokkumarprashanth primaryneuroendocrinetumorofthescrotumanuncommonsiteforararetumor AT corinesjames primaryneuroendocrinetumorofthescrotumanuncommonsiteforararetumor AT delarozagustavo primaryneuroendocrinetumorofthescrotumanuncommonsiteforararetumor AT basnetalina primaryneuroendocrinetumorofthescrotumanuncommonsiteforararetumor |